LXD Pro Series: Intellectual Property
Activity Director: Grace Omijie
Organization: MedStar Health System and Shared Services
ID: Od-033953
|
Chlorhexidine Gluconate (CHG): Treatment and Policy/Procedure.
Activity Director: Catherine Minter
Organization: MedStar Union Memorial Hospital
ID: Od-034474
|
Quiz-Chlorhexidine Gluconate (CHG) Treatment: Introduction to the new policy and procedure
Faculty: Elizabeth Gonder
Organization: MedStar Union Memorial Hospital
ID: Qu-018616
|
MWHC Pulmonary Services Withdrawing and Withholding Medical Treatment
Activity Director: Gail Drescher
Organization: MedStar Washington Hospital Center
ID: Od-031935
|
MGUH NICU: Eat, Sleep Console-An Approach for the Treatment of Neonatal Abstinence Syndrome
Activity Director: Anna DiMario
Organization: MedStar Georgetown University Hospital
ID: Od-036833
|
MedStar Health Clinical Practice Guideline for Treatment of Women with Hypertensive Disorders in Pregnancy for Nurses
Activity Director: Siobhan Ryan
Organization: MedStar Washington Hospital Center
ID: Od-029790
|
MWHC NICU: Eat, Sleep, Console - An Approach for the Treatment of Neonatal Abstinence Syndrome
Activity Director: Amy Grund
Organization: MedStar Washington Hospital Center
ID: Od-037985
|
Save Our Skin: Pressure Injury Prevention, Assessment, Treatment and Documentation
Activity Director: Kimberly Mauck
Organization: MedStar Georgetown University Hospital
ID: Od-034946
|
Inpatient SBIRT and Outreach Program Nurse Training: Medication Assisted Treatment
Activity Director: Cassandra Graziano
Organization: MedStar Washington Hospital Center
ID: Od-034177
|
MH CPGs for Treatment of Women with Hypertensive Disorders in Pregnancy & Magnesium Sulfate for Preeclampsia/Eclampsia
Activity Director: Tamika Auguste
Organization: MedStar Medical Group
ID: Od-034911
|
Smoking Cessation CE: Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting
Activity Director: Tracey Simon
Organization: MedStar Health System and Shared Services
ID: Od-033755
|
Opioid/Substance Use Disorders CE: Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035520
|
Opioid/Substance Use Disorders CE: Opioid Epidemic in the US Empirical Trends- Lit. Review of Social Determinants and Epidemiological, Pain Mgmt, and Treatment Patterns.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035522
|
Opioid/Substance Use Disorders CE: Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021.
Activity Director: John Yosaitis
Organization: MedStar Health System and Shared Services
ID: Od-035524
|